fig3

Figure 3. Impact on funding to support rare disease research. Respondents reported impacts on their normal processes for awarding grant funding (A) and received requests for extensions to existing grants, additional funding, and suspension of current grants (B). In response, many organizations offered more flexibility in grant submission deadlines and acceptance, as well as exploring opportunities to partner with other agencies to offer new calls for application (C).